Collegium Pharmaceutical (COLL) Depreciation & Amortization (CF) (2015 - 2020)

Collegium Pharmaceutical has reported Depreciation & Amortization (CF) for 6 years, with the latest figure at $195000.0 in Q3 2020.

• On a quarterly basis, Depreciation & Amortization (CF) rose 8.33% year-over-year to $195000.0 in Q3 2020; TTM through Jun 2021 was $195000.0, a 74.68% decrease from a year earlier, with the FY2019 full-year figure at $731000.0, down 31.94% from the prior year.
• Depreciation & Amortization (CF) was $195000.0 for Q3 2020 at Collegium Pharmaceutical, down from $196000.0 in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $482000.0 in Q1 2018, with the low at $43000.0 in Q1 2016.
• Average Depreciation & Amortization (CF) over 5 years is $191736.8, with a median of $184000.0 recorded in 2019.
• The sharpest annual moves came in 2016 and 2019: Depreciation & Amortization (CF) soared 619.51% in 2016, then plunged 61.83% in 2019.
• Over 5 years, Depreciation & Amortization (CF) stood at $295000.0 in 2016, then tumbled by 55.93% to $130000.0 in 2017, then soared by 163.08% to $342000.0 in 2018, then tumbled by 42.69% to $196000.0 in 2019, then retreated by 0.51% to $195000.0 in 2020.
• The last three Depreciation & Amortization (CF) figures came in at $195000.0 (Q3 2020), $196000.0 (Q2 2020), and $198000.0 (Q1 2020), per Business Quant data.